New drug to treat spinal muscular atrophy will be available on NHS
Around 1,500 people in England with the rare genetic disorder spinal muscular atrophy (SMA) are set to benefit from a new treatment following a...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.